LEADER 03536nam  2200637Ia 450 
001 9910462082103321
005 20200520144314.0
010   $a1-283-63636-0
010   $a0-309-25316-0
035   $a(CKB)2670000000275075
035   $a(EBL)3379028
035   $a(SSID)ssj0000665821
035   $a(PQKBManifestationID)11396035
035   $a(PQKBTitleCode)TC0000665821
035   $a(PQKBWorkID)10646588
035   $a(PQKB)10153786
035   $a(MiAaPQ)EBC3379028
035   $a(Au-PeEL)EBL3379028
035   $a(CaPaEBR)ebr10606369
035   $a(CaONFJC)MIL394882
035   $a(OCoLC)902942425
035   $a(EXLCZ)992670000000275075
100   $a20111220d2012      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aEnvisioning a transformed clinical trials enterprise in the United States$b[electronic resource] $eestablishing an agenda for 2020: workshop summary /$fNeil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy
210   $aWashington $cNational Academies Press$d2012
215   $a1 online resource (232 p.)
300   $aDescription based upon print version of record.
311   $a0-309-25315-2 
320   $aIncludes bibliographical references.
327   $a""Front Matter""; ""Reviewers""; ""Contents""; ""Tables, Figures, and Boxes""; ""Acronyms""; ""1 Introduction""; ""2 Integrating Community Practice and Clinical Trials""; ""3 Improving Public Participation in Clinical Trials""; ""4 Creating a New Business Model for Clinical Trials""; ""5 Building an Infrastructure to Support Clinical Trials""; ""6 Suggesting an Agenda for Transforming Elements of the Clinical Trials Enterprise""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Participant Biographies""; ""Appendix C: Registered Workshop Attendees""
327   $a""Appendix D: Discussion Paper: The Clinical Trials Enterprise in the United States: A Call for Disruptive Innovation""""Appendix E: Discussion Paper: Developing a Robust Clinical Trials Workforce""; ""Appendix F: Discussion Paper: Transforming the Economics of Clinical Trials""; ""Appendix G: Discussion Paper: Developing a Clinical Trials Infrastructure""; ""Appendix H: Discussion Paper: Canadian Strategy on Patient-Oriented Research""; ""Appendix I: Discussion Paper: Health Research as a Public Good""; ""Appendix J: Discussion Paper: Novel Ways to Get Good Trial Data: The UK Experience""
327   $a""Appendix K: IOM Staff Paper: Context and Glossary of Select Terms Associated with the Clinical Trials Enterprise""
606   $aClinical trials$zUnited States
606   $aClinical medicine$xResearch$zUnited States
608   $aElectronic books.
615  0$aClinical trials
615  0$aClinical medicine$xResearch
676   $a615.50724
701   $aWeisfeld$b Neil E$0897031
701   $aEnglish$b Rebecca A$0897032
701   $aClaiborne$b Anne B$0897033
712 02$aInstitute of Medicine (U.S.).$bForum on Drug Discovery, Development, and Translation.
712 02$aInstitute of Medicine (U.S.).$bBoard on Health Sciences Policy.
712 02$aNational Academies Press (U.S.)
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910462082103321
996   $aEnvisioning a transformed clinical trials enterprise in the United States$92004268
997   $aUNINA

LEADER 02025oam  2200589M  450 
001 9910716329803321
005 20200213070621.7
035   $a(CKB)5470000002520839
035   $a(OCoLC)1065989828
035   $a(OCoLC)995470000002520839
035   $a(EXLCZ)995470000002520839
100   $a20071213d1926      ua             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAmend act creating Bureau of Animal Industry. April 9, 1926. -- Referred to the House Calendar and ordered to be printed
210  1$a[Washington, D.C.] :$c[U.S. Government Printing Office],$d1926.
215   $a1 online resource (3 pages)
225 1 $aHouse report / 69th Congress, 1st session. House ;$vno. 817
225 1 $a[United States congressional serial set ] ;$v[serial no. 8533]
300   $aBatch processed record: Metadata reviewed, not verified. Some fields updated by batch processes.
300   $aFDLP item number not assigned.
606   $aAnimals$xDiseases
606   $aBabesiosis
606   $aCattle
606   $aExecutive departments
606   $aAdministrative agencies
606   $aLegislative amendments
606   $aPests$xControl
606   $aPest control baits
606   $aTicks
608   $aLegislative materials.$2lcgft
615  0$aAnimals$xDiseases.
615  0$aBabesiosis.
615  0$aCattle.
615  0$aExecutive departments.
615  0$aAdministrative agencies.
615  0$aLegislative amendments.
615  0$aPests$xControl.
615  0$aPest control baits.
615  0$aTicks.
701   $aHaugen$b Gilbert Nelson$f1859-1933$pRepublican (IA)$01386820
801  0$bWYU
801  1$bWYU
801  2$bOCLCO
801  2$bOCLCQ
906   $aBOOK
912   $a9910716329803321
996   $aAmend act creating Bureau of Animal Industry. April 9, 1926. -- Referred to the House Calendar and ordered to be printed$93514390
997   $aUNINA